- Home
- ACHV vs AGCC Comparison
ACHV vs AGCC Comparison
Compare ACHV & AGCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHV | AGCC |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.0M | 209.9M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | ACHV | AGCC |
|---|---|---|
| Price | $4.22 | $9.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 828.7K | 65.3K |
| Earning Date | 03-10-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $3,038,946.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $172.25 |
| Revenue Growth | N/A | ★ 186.00 |
| 52 Week Low | $1.84 | $3.66 |
| 52 Week High | $6.03 | $14.72 |
Technical Indicators
Market Signals| Indicator | ACHV | AGCC |
|---|---|---|
| Relative Strength Index (RSI) | 34.31 | 51.02 |
| Support Level | $4.05 | $9.06 |
| Resistance Level | $4.49 | $11.60 |
| Average True Range (ATR) | 0.34 | 1.42 |
| MACD | -0.18 | -0.12 |
| Stochastic Oscillator | 5.82 | 38.15 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares
Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.